-
- TANAKA SEIICHI
- Tsukuba Research Institute in collaboration with Merck Research Laboratories, Banyu Pharmaceutical Co., Ltd.
-
- OKABE TAKAYOSHI
- Tsukuba Research Institute in collaboration with Merck Research Laboratories, Banyu Pharmaceutical Co., Ltd.
-
- NAKAJIMA SHIGERU
- Tsukuba Research Institute in collaboration with Merck Research Laboratories, Banyu Pharmaceutical Co., Ltd.
-
- YOSHIDA EISAKU
- Tsukuba Research Institute in collaboration with Merck Research Laboratories, Banyu Pharmaceutical Co., Ltd.
-
- MORISHIMA HAJIME
- Tsukuba Research Institute in collaboration with Merck Research Laboratories, Banyu Pharmaceutical Co., Ltd.
書誌事項
- タイトル別名
-
- III. SYNTHESIS
この論文をさがす
説明
In a preceding paper, the physico-chemical properties and structural elucidation of BE-23372M, a potent novel protein tyrosine kinase inhibitor, were described. In this paper, we report the synthesis of BE-23372M from 3-(3, 4-dimethoxybenzoyl)propionic acid and veratraldehyde or 3, 4-diacetoxy-benzaldehyde. The structure of BE-23372M was confirmed to be (E)-3-(3, 4-dihydroxybenzylidene)-5-(3, 4-dihydroxyphenyl)-2(3H)-furanone.
収録刊行物
-
- The Journal of Antibiotics
-
The Journal of Antibiotics 47 (3), 297-300, 1994
公益財団法人 日本感染症医薬品協会